Previous Article | Next Article 
Infection and Immunity, July 1999, p. 3297-3301, Vol. 67, No. 7
Defence Evaluation and Research Agency,
Received 23 December 1998/Returned for modification 18 February
1999/Accepted 3 April 1999
The phospholipases C of C. perfringens (alpha-toxin)
and C. bifermentans (Cbp) show >50% amino acid homology
but differ in their hemolytic and toxic properties. We report here the
purification and characterisation of alpha-toxin and Cbp. The
phospholipase C activity of alpha-toxin and Cbp was similar when tested
with phosphatidylcholine in egg yolk or in liposomes. However, the hemolytic activity of alpha-toxin was more than 100-fold that of Cbp.
To investigate whether differences in the carboxy-terminal domains of
these proteins were responsible for differences in the hemolytic and
toxic properties, a hybrid protein (NbiC In 1941 MacFarlane and Knight
(9) reported a breakthrough in the understanding of the
biochemical basis of bacterial disease by showing that the alpha-toxin
of Clostridium perfringens was a phospholipase C enzyme.
This finding prompted a number of studies to characterize the
phospholipases C from other species of clostridia in the anticipation
that they, too, would possess toxic properties. However, this
possibility was soon disproved by Miles and Miles (11), who
showed that the Clostridium bifermentans phospholipase C
(Cbp) was, by their criteria, nontoxic. Attempts to explain this
difference focused on the lower phospholipase C and hemolytic activities of the C. bifermentans enzyme, and MacFarlane
(10) proposed that the toxicity of the C. perfringens and C. bifermentans enzymes correlated with
hemolytic activity rather than with phospholipase C activity. The
molecular basis for these differences have been speculated upon but not
examined in detail until more recently. The alpha-toxin is now known to
be composed of two domains (16). The isolated N-terminal
domain possessed the phosphatidylcholine phospholipase C activity of
the holotoxin, but was devoid of hemolytic and lethal activities, and
showed reduced sphingomyelinase activity (24). The isolated
C-terminal domain was devoid of any detectable biological activity but
appeared to confer hemolytic, lethal, and sphingomyelinase activities
on the toxin (22, 24). Studies with site-directed mutants of
the toxin have confirmed that N-domain mutants with abolished
phosphatidylcholine phospholipase C activity also show loss of
hemolytic and lethal activities (5, 13), confirming that the
phospholipase C activity of the toxin is necessary for all of the
biological activities.
The crystal structure of alpha-toxin (16) reveals that the C
domain is organized into a A comparison of the deduced amino acid sequences of the C. perfringens and C. bifermentans proteins revealed 51%
overall homology (26), and the amino acid sequence alignment
suggests that Cbp is also a two-domain protein (23, 26).
This alignment also reveals differences in key residues involved in
calcium and phospholipid binding within the C domains. These
differences in the C domain of Cbp could result in diminished calcium
binding and therefore reduce the ability of the protein to interact
with membranes, resulting in its lowered hemolytic activity. We
have set out to compare the properties of the C. perfringens and C. bifermentans phospholipases C and to
construct a hybrid form of the C. perfringens and C. bifermentans proteins, with a view towards determining whether the
N or C domains of these enzymes are responsible for the differences in
activity of these enzymes.
Chemicals and enzymes.
All chemicals were obtained
from Sigma (Poole, United Kingdom) or BDH (Poole, United Kingdom)
unless otherwise stated. Materials for protein purification were
obtained from Pharmacia Biotech. Materials for DNA purification were
obtained from Boehringer Mannheim (Lewes, United Kingdom).
Isolation of DNA.
Escherichia coli containing plasmids
pKS Expression of the C. bifermentans phospholipase C
gene (cbp).
The C. bifermentans
phospholipase C gene was amplified by PCR (20) with plasmid
pCBPLC3 (encoding cbp) as the template DNA and
oligonucleotides NbifUP (5'-GCTTGGGGCCCAAGATTAGAGGATATTA-3') and CbiRev (5'-TGCTCTAGATTATTTATTTATGTAATAAGT-3') for
PCR amplification of the DNA fragment. The DNA fragment obtained after
35 cycles of amplification (95°C, 15 s; 50°C, 15 s;
72°C, 30 s; Perkin-Elmer 9600 GeneAmp PCR system) was purified,
digested with the appropriate restriction endonucleases, ligated with
plasmid vector p Nucleotide sequencing.
Extension reactions with
dithiothreitol chemistry and containing 500 ng of template DNA and 4.8 pmol of primer were prepared by using ABI 800 Molecular Biology
Labstation Catalyst overnight at 50°C. Sequence analysis was carried
out with an Applied Biosystems 373A sequencer. The nucleotide sequence
of the cpb gene, encoding the C. bifermentans
phospholipase C, has been deposited in GenBank (accession number
AF072123).
Cloning of the N and C domains.
DNA fragments, which encoded
the N domain of alpha-toxin or the C domain of Cbp were amplified by
PCR (20) with either oligonucleotides NbifUP and NbiREV
(5'-CGGGGTACCTATGACGTCTCCTGTATTTCC-3') or oligonucleotides CaUP (5'-TGCTCTAGACCAGACGTCGAAAGAATGTA-3') and CaREV
(5'-TGCTCTAGATTATTTTATATTATAAGTTGA-3'). The template DNA for
these reactions was either plasmid pKS Purification of phospholipase C.
Phospholipase C was
extracted from the periplasmic space of E. coli cells as
described previously (25). The phospholipase C was purified
by using two successive fast protein liquid chromatography (FPLC)
ion-exchange chromatography steps. The crude extract was initially
applied to a FPLC anion-exchange chromatography column (3.2 by 25 cm;
DEAE Sephacel) and eluted with a 0 to 100% (0 to 1 M) sodium chloride
gradient at a flow rate of 0.2 ml/m. Fractions (10 ml) were collected,
and those containing phospholipase C were concentrated by stirred-cell
ultrafiltration (Amicon) under nitrogen pressure through a blocked
membrane. The concentrated sample was buffer exchanged into 10 mM
Tris-HCl (pH 8.0) and applied to a second anion-exchange chromatography
column (MonoQ HR10/10). Protein was eluted with a 0 to 100% (0 to 1 M)
NaCl gradient at a flow rate of 0.2 ml/m. For Cbp, the protein was
further purified by using a gel filtration column (FPLC; Superose12)
and eluted in phosphate-buffered saline (0.1 M sodium phosphate, 0.9%
[wt/vol] NaCl; pH 7.2) at a flow rate of 0.2 ml/m. Fractions
containing phospholipase C were collected manually, pooled, and
concentrated by stirred-cell ultrafiltration. The concentrated sample
was buffer exchanged into 10 mM Tris-HCl (pH 8.0), and the final
preparations were stored at
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Differences in the Carboxy-Terminal (Putative Phospholipid
Binding) Domains of Clostridium perfringens and
Clostridium bifermentans Phospholipases C Influence the
Hemolytic and Lethal Properties of These Enzymes
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) was constructed comprising the N domain of Cbp and the C domain of
alpha-toxin. The hemolytic activity of NbiC
was 10-fold that of Cbp, and the hybrid enzyme was toxic. These results
confirm that the C-terminal domain of these proteins confers different properties on the enzymatically active N-terminal domain of these proteins.
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-sandwich, termed a C2 domain. The C
domain of alpha-toxin has a topology similar to that of the
calcium-dependent phospholipid binding domains of some eukaryotic proteins, namely, pancreatic lipase, synaptotagmin I, human
arachidonate 5-lipoxygenase (HA5L), and
phosphoinositide-specific phospholipase C
1
(15). These eukaryotic proteins share little overall
sequence homology with alpha-toxin, but aspartic acid residues involved in calcium binding in the C2 domain of HA5L are conserved in the alpha-toxin C domain (16). Using site-directed mutagenesis, Guillouard et al. (6) showed that Asp269 and
Asp336 (Fig. 1) were
essential for alpha-toxin activity and suggested that these residues
are involved in calcium binding. Naylor et al. (16) have
designated the area coordinated by these key aspartic acid residues and
other residues (Gly271 and Ala337) as a
calcium-binding site in the C domain of alpha-toxin.
View larger version (62K):
[in a new window]
FIG. 1.
Alignment of the deduced amino acid sequences of
C. perfringens alpha-toxin (Cpa) and C. bifermentans phospholipase C (Cbp). Symbols: 
, region
(Ser250 and Val251) at which a unique
AatII restriction site (Asp-Val) was introduced; *,
aspartic acid residues thought to be involved in calcium binding in the
C domain of alpha-toxin.
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
3, pCBPLC3, or pPROM27 were grown in L broth containing
ampicillin at 37°C overnight (20). Plasmid DNA was
isolated from the cell pellet by the Qiagen procedure.
PROM27 containing the alpha-toxin promoter, and
transformed into E. coli JM109 cells by electroporation
(20). Colonies containing the cloned cbp DNA
fragment were identified by PCR with the oligonucleotides NbifUP and CbiRev.
3 (encoding alpha-toxin) or
plasmid pCBPLC3 (encoding Cbp). The DNA fragments obtained after 35 cycles of amplification (95°C, 15 s; 50°C, 15 s; 72°C,
30 s; Perkin-Elmer 9600 GeneAmp PCR System) were purified,
digested with the appropriate restriction endonucleases, ligated with
plasmid vector pBluescript KS(+) (Stratagene), and transformed into
E. coli JM109 cells by electroporation (20). Colonies containing the cloned DNA fragments were identified by PCR
with the oligonucleotides described above.
20°C. Protein content was determined by
using the bicinchoninic acid protein assay. Purified products were
analyzed by sodium dodecyl sulfate-10 to 15% polyacrylamide gel
electrophoresis by using a PhastSystem and were judged to be >95%
pure (Fig. 2). Gels were stained with
Coomassie blue R250. The yields of purified alpha-toxin, Cbp, and
hybrid NbiC were 10, 5, and 15 mg, respectively.
View larger version (51K):
[in a new window]
FIG. 2.
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis of purified phospholipases C. C. bifermentans Cbp (lane 1), hybrid NbiC
(lane 2), C. perfringens alpha-toxin (lane 3), and molecular
mass weight markers in kilodaltons (lane 4) are shown.
CD spectroscopy studies. Secondary structures of the purified proteins were determined by using circular dichroism spectroscopy (CD) in a Jasco J-720 spectropolarimeter at 25 ± 1°C. The bandwidth was either 1 or 2 nm with a response time of 1 s, and data were collected at between 178 and 260 nm for far-UV by using 0.01-cm demountable and 0.05-cm cylindrical quartz cells. Data were collected at between 250 and 320nm for near-UV by using 1-cm pathlength quartz cuvettes (Hellma GmbH) at 0.5-nm intervals, with averaging for 9, 16, or 25 scans. Varselec 1 software was applied to the CD spectrum between 178 and 260 nm, with a 33-protein basis set, to calculate secondary-structure composition.
Biological activities of the phospholipases C. Phospholipase C activity was measured by egg yolk assay emulsion in a microtiter assay (25) or by using a modified version of the protocol by Kurioka et al. (8), with p-nitrophenylphosphorylcholine (pNPPC; 40 mM in water). The absorbance was read at 414 nm (pNPPC) or 540nm (egg yolk) on a Titertek Multiscan MCC/340 Platereader (Life Sciences). Liposomes composed of either phosphatidylcholine (Lipoid) or sphingomyelin encapsulating carboxyfluorescein (CF) were prepared according to the method of Nagahama et al. (14). The liposomes were probe sonicated as an additional step after drying and hydration of the liposomes. Phospholipase C (100 µl), at various concentrations, was incubated with liposomes (100 µl) at 37°C for 1 h. Fluorescence intensity was measured with a luminescence spectrometer LS-5B (Perkin-Elmer, excitation at 485 nm, emission at 520 nm). A 100% CF release was determined by incubation of liposomes with 1% Triton X-100 at 37°C for 1 h. Hemolytic activity was determined by using mouse erythrocytes (5% [vol/vol]) in a microtiter tray assay as described previously (25).
Toxicity in mice. The toxicity of the phospholipases C was determined by intraperitoneal injection of 50 µl of purified toxin (in saline) into groups of four BALB/c mice. The mice were monitored for 18 h after injection.
Complementation of the C domain. The isolated C domain of alpha-toxin was incubated with mouse erythrocytes which had been preincubated with phospholipase C, and the hemolytic activity was determined as described above.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Cloning and expression of C. perfringens
alpha-toxin and C. bifermentans phospholipase C.
C. perfringens NCTC 8237 alpha-toxin was expressed in
E. coli as described previously (25). The
plasmid-cloned gene encoding the C. bifermentans
phospholipase (26) (cbp) was nucleotide sequenced, and seven differences between the previously reported sequence (26) were found. These differences resulted in six amino acid sequence changes (Tyr31
Ser31,
Ser94Ala94,
Arg95Glu95, Asn96Thr96,
Ser97Gln97, and
Ile252Asp252). The level of expression of
the cloned C. bifermentans phospholipase C gene
(cbp) from the native promoter in E. coli was
low. To increase the level of expression, the cbp open
reading frame was amplified by PCR and cloned downstream of the
C. perfringens alpha-toxin promoter. Nucleotide sequencing
of the cloned fragment confirmed the authenticity of the cbp gene.
Construction of a C. perfringens-C. bifermentans hybrid
phospholipase C.
Previous studies have shown that the C. perfringens alpha-toxin is composed of two domains (N and C
domains) linked by a potentially flexible region (16). An
alignment of the deduced amino acid sequences of the alpha-toxin and
Cbp (Fig. 1) suggested a similar organization of these proteins, and we
considered that by modifying the linker region
(Ser250-Val251 in alpha-toxin or
Asp250-Asn251 in Cbp) to encode Asp-Val in both
proteins we would be able to introduce a unique AatII
restriction site into the coding DNA. To introduce this site, the
regions of DNA encoding the N domain of Cbp or the C domain of
alpha-toxin were amplified by PCR with appropriately tailed PCR
primers. The changes in the amino acid sequence did not affect the
phospholipase C or hemolytic activities of alpha-toxin or Cbp (data not
shown). To construct the hybrid phospholipase C, the DNA fragment
encoding the N domain of Cbp was fused with the C. perfringens
cpa promoter sequence. The DNA fragments were ligated at the
AatII site to generate a gene encoding a hybrid C. perfringens-C. bifermentans phospholipase C (hybrid NbiC).
CD spectroscopy study of the enzymes.
Purified alpha-toxin,
Cpb, or hybrid NbiC were analyzed by using
circular dichroism spectroscopy. Secondary-structure composition was
determined with Varselec 1 software applied to the CD spectrum at
between 178 and 260 nm with a 33-protein basis set. The alpha-toxin
was shown to consist of 43% -helix, 12% -sheet, and 16% turn,
which is consistent with the crystal structure data (44% -helix,
18% -sheet, and 4% turn [15a]). Cbp contained 40% -helix, 15% -sheet, and 15% turn. Hybrid
NbiC consisted of 43% -helix, 15%
-sheet, and 15% turn.
Phospholipase C: hemolytic and lethal activity of the alpha-toxin and Cpb. The specific activities of alpha-toxin or Cbp were determined by using a variety of assays. The activity of the alpha-toxin or Cbp towards sphingomyelin liposomes was increased 127- and 146-fold, respectively (mean of three determinations), when the assays were carried out in the presence of 2.5 mM Ca2+. Enhancement of activity towards murine erythrocytes in the presence of 2.5 mM Ca2+ was also observed (data not shown). All subsequent assays were carried out in the presence of 2.5 mM Ca2+ ions.
The alpha-toxin was more active in all of the assays compared with the other enzymes (Table 1). However, the ratio of alpha-toxin activity to Cbp activity depended on the form of the substrate. When phosphatidylcholine in egg yolk or in liposomes was used, alpha-toxin was twice as active as Cbp. When tested with sphingomyelin liposomes, alpha-toxin was 10 times as active as Cbp. When a synthetic substrate with the phosphorylcholine head group linked to p-nitrophenyl (pNPPC) was used, alpha-toxin was 24 times as active as Cbp. The hemolytic activity of alpha-toxin was 132 times that of Cbp when tested with mouse erythrocytes. When administered intraperitoneally into mice, 10 µg of Cbp did not cause any deaths over a period of 18 h, whereas 1 µg of alpha-toxin resulted in the death of all of the mice within 2.5 h (Table 2).
|
|
Phospholipase C: hemolytic and lethal activity of hybrid
NbiC.
The replacement of the C
domain of Cbp with the corresponding region from alpha-toxin
yielded an enzymatically active protein (NbiC) which, on the basis of CD analysis,
was correctly folded. The hybrid phospholipase C had properties that
were intermediate between the two parent enzymes (Table 1). The
specific activity of hybrid NbiC was broadly
similar to alpha-toxin and Cbp when tested with egg yolk
phosphatidylcholine or with liposomes composed of phosphatidylcholine.
The activity of hybrid NbiC was greater than
the activity of Cbp when assayed with liposomes composed of
sphingomyelin. The hemolytic activity of hybrid
NbiC was increased 10-fold compared to Cbp
but was lower than the activity of the alpha-toxin. When administered
intraperitoneally into mice, hybrid NbiC
phospholipase was intermediate in toxicity between Cbp and alpha-toxin
(Table 2).
Complementation of the C domain. Guillouard et al. (6) reported that mutation of residue Thr272 to Pro272 in alpha-toxin results in the abolition of phospholipase C and hemolytic activity. They further reported that hemolytic activity was restored when the isolated C domain of alpha-toxin was added to a solution of this mutated protein. When purified C domain of the alpha-toxin was added to a solution of alpha-toxin (78 hemolytic units [HU]) or Cbp (14 HU), there was no significant increase in the hemolytic activity of either of these enzymes (86 and 13 HU, respectively; all data are the mean of two determinations).
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Phospholipases produced by pathogenic bacteria have been shown to play a variety of roles in the pathogenesis of disease (12, 21, 23). In the case of alpha-toxin, the enzyme has been shown to activate the arachidonic acid cascade and protein kinase C in eukaryotic cells (4, 7, 18, 19), and the toxic effects (1) might be a result of this perturbation of host cell metabolism. These changes in host cell metabolism are a result of the accumulation of diacylglycerol within the host cell, and the ability of bacterial phospholipases C to hydrolyze membrane phospholipids, yielding diacylglycerol, provides an obvious role for these enzymes in this process. Within cell membranes the phospholipid head groups are packed together, shielding the ester bond which is the target of the alpha-toxin (2). Therefore, it has been suggested that alpha-toxin is able to insert into the cell membrane (16). Hemolysis is often used as an indicator of activity towards membrane phospholipids.
The C. bifermentans Cbp has been shown to be nontoxic and weakly hemolytic when compared to alpha-toxin (26), and previous studies have suggested that these properties can be explained by the correspondingly reduced phospholipase C activity (23, 26). Our findings indicate that the phospholipase C activity of Cbp towards some substrates, such as egg yolk phosphatidylcholine or phosphatidylcholine liposomes, is close to the activity of alpha-toxin. Several studies have suggested that the ability of some bacterial phospholipases to cause hemolysis is due to their ability to hydrolyze both phosphatidylcholine and sphingomyelin (17, 23, 24), and it may be significant that Cbp was 10-fold less active than alpha-toxin toward sphingomyelin in liposomes. However, this difference in substrate preference does not provide a full explanation for the >100-fold difference in the hemolytic activity of Cbp and alpha-toxin. Our finding that purified alpha-toxin was at least 10 times as toxic to mice as Cbp lends support to the suggestion that hemolytic activity provides an in vitro indicator of toxicity.
Crystallographic studies show that alpha-toxin is composed of an active site domain (N domain) and a calcium-binding domain (C domain), which are linked by a flexible peptide (16). Removal of the C domain from alpha-toxin abolished hemolytic activity (but not the phospholipase C activity), and antisera against the C domain neutralized hemolytic activity (27), cytotoxicity towards UDP-glucose-deficient cells (3), and lethality (27). It is possible that this domain plays a role in the recognition of membrane phospholipids. Naylor et al. (16) have constructed a model indicating how surface-exposed hydrophobic side chains (Tyr331 and Phe334) and calcium ions coordinated by the phospholipid phosphate group and the C domain allow alpha-toxin to become inserted into membranes. Our finding that the activity of alpha-toxin and Cbp were similarly stimulated by Ca2+ ions and that, with the exception of Asp269 (Tyr in Cbp), Ca2+-binding ligands are conserved in both alpha-toxin and Cbp indicates that the differences in cytolytic properties of these proteins are not due to differences in Ca2+-mediated recognition of phospholipids. However, Tyr331 and Phe334 in the C domain of alpha-toxin are replaced in Cbp by residues, which are unlikely to play similar roles (Leu and Ile, respectively).
The data we have reported here provide the first evidence that the function of the C domains of alpha-toxin and Cbp are not identical. Replacement of the Cbp C domain with the C domain from alpha-toxin enhanced the hemolytic activity of the enzyme 10-fold, which would be expected if the C domain plays a key role in membrane phospholipid recognition. However, structural motifs in the N domain are also thought to play a role in the recognition of membrane phospholipids (Trp214). This would explain why replacement of the Cbp C domain with the alpha-toxin C domain did not fully restore hemolytic activity. Although Guillouard et al. have shown that the low hemolytic activity of mutated forms of alpha-toxin could be complemented by adding the wild-type C domain of alpha-toxin, we were not able to demonstrate a similar effect by adding the alpha-toxin C domain to Cbp.
The finding that replacement of the Cbp C domain with the C domain from alpha-toxin increased its activity toward pNPPC was unexpected because this substrate lacks a hydrocarbon tail group. In previous studies with the alpha-toxin it was shown that removal of the C domain increased the activity of the enzyme toward pNPPC, a result which was attributed to the enhanced accessibility of the active site (24). Although the overall conformation of Cbp appeared to be similar to that of alpha-toxin, it is possible that the different C domains modify the accessibility of the active site to pNPPC. The determination of the structure of the Cbp might answer this question.
The findings reported here suggest a similar phospholipid-recognizing role for the C domain in other hemolytic zinc-metallophospholipases C, such as the C. novyi gamma-toxin. Whether other bacterial phospholipases such as those produced by Mycobacterium tuberculosis and Pseudomonas aeruginosa possess similar phospholipid-binding domains awaits investigation. However, the overall amino acid sequence homology between the alpha-toxin C domain and the calcium-dependent phospholipid-binding domains of synaptotagmin, phosphatidylinositol phospholipase C, and pancreatic lipase is low (15, 16), and the identification of domains with similar functions in other hemolytic bacterial phospholipases C may not be possible on the basis of sequence homology alone. Nevertheless, it seems likely that these hemolytic enzymes do possess specialized features which allow membrane phospholipid recognition.
| |
ACKNOWLEDGMENTS |
|---|
We thank Y. Tso (Protein Design Labs, Inc., Palo Alto, Calif.) for providing plasmid pCBPLC3 and D. Moss, A. Basak, and C. Naylor (Birkbeck College, London, United Kingdom) for helpful discussions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Defence Evaluation and Research Agency, CBD Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom. Phone: 1980-613301. Fax: 1980-613284. E-mail: 100655,2360{at}compuserve.com.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. |
Asmuth, D. M.,
R. D. Olson,
S. P. Hackett,
A. E. Bryant,
R. K. Tweten,
J. Y. Tso,
T. Zollerman, and D. L. Stevens.
1995.
Effects of Clostridium perfringens recombinant and crude phospholipase C and  -toxin on rabbit hemodynamic parameters.
J. Infect. Dis.
172:1317-1323[Medline].
|
| 2. | El-Sayed, M. Y., C. D. DeBose, L. A. Coury, and M. F. Roberts. 1985. Sensitivity of phospholipase C (Bacillus cereus) activity to phosphatidylcholine structural modifications. Biochim. Biophys. Acta 837:325-335[Medline]. |
| 3. |
Flores-Díaz, M.,
A. Alape-Girón,
R. W. Titball,
M. Moos,
I. Guillouard,
S. Cole,
C. von Eichel-Streiber, and M. Thelestam.
1998.
Cellular UDP-glucose deficiency causes hypersensitivity to Clostridium perfringens phospholipase C.
J. Biol. Chem.
273:24433-24438 |
| 4. | Fujii, Y., and J. Sakurai. 1989. Contraction of the rat isolated aorta caused by Clostridium perfringens alpha-toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism. Br. J. Pharmacol. 97:119-124[Medline]. |
| 5. | Guillouard, I., T. Garnier, and S. T. Cole. 1996. Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens. Infect. Immun. 64:2440-2444[Abstract]. |
| 6. |
Guillouard, I.,
P. M. Alzari,
B. Saliou, and S. T. Cole.
1997.
The carboxy-terminal C2-like domain of the -toxin from Clostridium perfringens mediates calcium-dependent membrane recognition.
Mol. Microbiol.
26:867-876[Medline].
|
| 7. | Gustafson, C., and C. Tagesson. 1990. Phospholipase C from Clostridium perfringens stimulates phospholipase A2-mediated arachidonic acid release in cultured intestinal epithelial cells (INT 407). Scand. J. Gastroenterol. 25:363-371[Medline]. |
| 8. | Kurioka, S., and M. Matsuda. 1976. Phospholipase C assay using p-nitrophenylphosphorylcholine and its application to studying the metal and detergent requirement of the enzyme. Anal. Biochem. 75:281-289[Medline]. |
| 9. | MacFarlane, M. G., and B. C. J. G. Knight. 1941. The biochemistry of bacterial toxins. I. Lecithinase activity of Cl. welchii toxins. Biochem. J. 35:884-902. |
| 10. | MacFarlane, M. G. 1955. On the biochemical mechanism of action of gas-gangrene toxin, p. 57-77. In Mechanisms of Microbial Pathogenicity (5th Symposium of the Society for General Microbiology) Cambridge University Press, Cambridge, England. |
| 11. |
Miles, E. M., and A. A. Miles.
1947.
The lecithinase of Clostridium bifermentans and its relation to the -toxin of Clostridium welchii.
J Gen Microbiol
1:385-399.
|
| 12. | Mollby, R. 1978. Bacterial phospholipases, p. 367-424. In J. Jeljaszewicz, and T. Wadstrom (ed.), Bacterial toxins and cell membranes. Academic Press, Ltd., London, England. |
| 13. |
Nagahama, M.,
Y. Okagawa,
T. Nakayama,
E. Nishioka, and J. Sakurai.
1995.
Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin.
J. Bacteriol.
177:1179-1185 |
| 14. | Nagahama, M., K. Michiue, and J. Sakurai. 1996. Membrane-damaging action of Clostridium perfringens alpha-toxin on phospholipid liposomes. Biochim. Biophys. Acta 1280:120-126[Medline]. |
| 15. | Nalefski, E. A., and J. J. Falke. 1996. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci. 12:2375-2390. |
| 15a. | Naylor, C. E. Personal communication. |
| 16. | Naylor, C. E., J. T. Eaton, A. Howells, N. Justin, D. S. Moss, R. W. Titball, and A. K. Basak. 1998. The structure of the key toxin in gas gangrene has a prokaryotic calcium-binding C2 domain. Nat. Struct. Biol. 5:738-746[Medline]. |
| 17. |
Ostroff, R. M.,
A. I. Vasil, and M. L. Vasil.
1990.
Molecular comparison of a nonhemolytic and a hemolytic phospholipase C from Pseudomonas aeruginosa.
J. Bacteriol.
172:5915-5923 |
| 18. |
Sakurai, J.,
S. Ochi, and H. Tanaka.
1994.
Regulation of Clostridium perfringens alpha-toxin-activated phospholipase C in rabbit erythrocyte membranes.
Infect. Immun.
62:717-721 |
| 19. |
Sakurai, J.,
S. Ochi, and H. Tanaka.
1993.
Evidence for coupling of Clostridium perfringens alpha-toxin-induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes.
Infect. Immun.
61:3711-3718 |
| 20. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbour, N.Y. |
| 21. | Songer, J. G. 1997. Bacterial phospholipases and their role in virulence. Trends Microbiol. 5:156-161[Medline]. |
| 22. | Titball, R. W., A. M. Fearn, and E. D. Williamson. 1993. Biochemical and immunological properties of the C-terminal domain of the alpha-toxin of Clostridium perfringens. FEMS Microbiol. Lett. 110:45-50[Medline]. |
| 23. |
Titball, R. W.
1993.
Bacterial phospholipases C.
Microbiol. Rev.
57:347-366 |
| 24. |
Titball, R. W.,
D. L. Leslie,
S. Harvey, and D. C. Kelly.
1991.
Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway.
Infect. Immun.
59:1872-1874 |
| 25. |
Titball, R. W.,
S. E. C. Hunter,
K. L. Martin,
B. C. Morris,
A. D. Shuttleworth,
T. Rubidge,
D. W. Anderson, and D. C. Kelly.
1989.
Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens.
Infect. Immun.
57:367-376 |
| 26. |
Tso, J. Y., and C. Siebel.
1989.
Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans.
Infect. Immun.
57:468-476 |
| 27. | Williamson, E. D., and R. W. Titball. 1993. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens also protects mice against experimental gas gangrene. Vaccine 11:1253-1258[Medline]. |
Infection and Immunity, July 1999, p. 3297-3301, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
DebRoy, S., Aragon, V., Kurtz, S., Cianciotto, N. P.
(2006). Legionella pneumophila Mip, a Surface-Exposed Peptidylproline cis-trans-Isomerase, Promotes the Presence of Phospholipase C-Like Activity in Culture Supernatants. Infect. Immun.
74: 5152-5160
[Abstract] [Full Text] -
Flores-Diaz, M., Alape-Giron, A., Clark, G., Catimel, B., Hirabayashi, Y., Nice, E., Gutierrez, J.-M., Titball, R., Thelestam, M.
(2005). A Cellular Deficiency of Gangliosides Causes Hypersensitivity to Clostridium perfringens Phospholipase C. J. Biol. Chem.
280: 26680-26689
[Abstract] [Full Text] -
Karasawa, T., Wang, X., Maegawa, T., Michiwa, Y., Kita, H., Miwa, K., Nakamura, S.
(2003). Clostridium sordellii Phospholipase C: Gene Cloning and Comparison of Enzymatic and Biological Activities with Those of Clostridium perfringens and Clostridium bifermentans Phospholipase C. Infect. Immun.
71: 641-646
[Abstract] [Full Text] -
Aragon, V., Rossier, O., Cianciotto, N. P.
(2002). Legionella pneumophila genes that encode lipase and phospholipase C activities. Microbiology
148: 2223-2231
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»